Oruka Therapeutics Inc.
ORKA | NASDAQ
$97.70
+$0.83 (+0.86%)
Nov 2, 2026, 9:55 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 43K | 43K | 28K | n/a | n/a | n/a | n/a | n/a | n/a | 19K | 23K | 30K | 29K | 29K | 29K | 28K | 29K | 28K | 28K | 27K | 19K | 17K |
Gross Profit | -43K | -43K | -28K | n/a | n/a | n/a | n/a | n/a | n/a | -19K | -23K | -30K | -29K | -29K | -29K | -28K | -29K | -28K | -28K | -27K | -19K | -17K |
Operating Income | -50.11M | -36.43M | -34.43M | -34.11M | -28.43M | -25.09M | -38.33M | -29.45M | -21.49M | -2.48M | -1.59M | -1.94M | -1.97M | -1.8M | -1.58M | -1.76M | -2.43M | -3.28M | -5.68M | -4.72M | -4.84M | -4.1M |
Interest Income | 8.9M | 4.61M | 4.85M | 3.83M | 3.86M | 4.09M | 4.53M | 1.33M | 444K | 473K | 501K | 513K | 493K | 450K | 675K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -41.21M | -31.82M | -29.58M | -30.28M | -24.57M | -21M | -33.39M | -28.62M | -22.24M | -2.01M | -1.09M | -1.42M | -1.48M | -1.35M | -1.17M | -2.33M | -3.15M | -3.27M | -5.68M | -4.71M | -4.83M | -4.1M |
Net Income | -41.21M | -31.82M | -29.58M | -30.28M | -24.57M | -21M | -33.39M | -28.62M | -22.24M | -2.01M | -1.09M | -1.42M | -1.48M | -1.35M | -1.17M | -2.33M | -3.15M | -3.27M | -5.68M | -4.71M | -4.83M | -4.1M |
Selling & General & Admin | 6.81M | 7.25M | 6.76M | 5.12M | 4.34M | 5.16M | 6M | 3.76M | 2.82M | 1.67M | 1.52M | 1.59M | 1.69M | 1.38M | 1.29M | 1.2M | 1.41M | 1.07M | 1.71M | 1.25M | 1.24M | 1.21M |
Research & Development | 43.26M | 29.15M | 27.64M | 28.99M | 24.09M | 19.93M | 32.33M | 25.69M | 18.67M | 165K | 47K | 322K | 254K | 390K | 266K | 534K | 995K | 2.18M | 3.94M | 3.44M | 3.58M | 2.88M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | 628K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 50.06M | 36.39M | 34.4M | 34.11M | 28.43M | 25.09M | 38.33M | 29.45M | 21.49M | 2.46M | 1.57M | 1.91M | 1.94M | 1.77M | 1.55M | 1.73M | 2.4M | 3.25M | 5.65M | 4.69M | 4.82M | 4.09M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 504K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 200K | n/a | n/a | 327.27K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 50.11M | 36.43M | 34.43M | 34.11M | 28.43M | 25.09M | 38.33M | 29.45M | 21.49M | 2.48M | 1.59M | 1.94M | 1.97M | 1.8M | 1.58M | 1.76M | 2.43M | 3.28M | 5.68M | 4.72M | 4.84M | 4.1M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 62.87M | 55.17M | 54.42M | 44.07M | 42.23M | 41.68M | 16.79M | 15.01M | 14.51M | 14.5M | 14.42M | 14.41M | 14.41M | 14.41M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.03M |
Shares Outstanding (Diluted) | 62.87M | 55.17M | 54.42M | 44.07M | 42.23M | 41.68M | 16.79M | 15.01M | 14.51M | 14.5M | 14.42M | 14.41M | 14.41M | 14.41M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.03M |
EPS (Basic) | -0.66 | -0.58 | -0.54 | -0.69 | -0.58 | -0.50 | -1.54 | -1.91 | -1.30 | -0.24 | -0.90 | -1.19 | -1.23 | -1.12 | -0.98 | -1.94 | -2.62 | -2.72 | -4.73 | -3.92 | -4.03 | -3.98 |
EPS (Diluted) | -0.66 | -0.58 | -0.54 | -0.69 | -0.58 | -0.50 | -1.54 | -1.91 | -1.30 | -0.24 | -0.90 | -1.19 | -1.23 | -1.12 | -0.98 | -1.94 | -2.62 | -2.72 | -4.73 | -3.92 | -4.03 | -3.98 |
EBITDA | -50.06M | -31.78M | -29.56M | -30.26M | -24.56M | -20.98M | -37.44M | -28.12M | -22.23M | -1.99M | -1.07M | -1.39M | -1.45M | -1.32M | -1.15M | -2.31M | -3.12M | -3.24M | -5.65M | -4.69M | -4.82M | -4.08M |
EBIT | -50.11M | -31.82M | -29.58M | -30.28M | -24.57M | -21M | -37.46M | -28.12M | -22.24M | -2.01M | -1.09M | -1.42M | -1.48M | -1.35M | -1.17M | -2.33M | -3.15M | -3.27M | -5.68M | -4.71M | -4.83M | -4.1M |
Depreciation & Amortization | 43K | 43K | 28K | 20K | 19K | 16K | 18.46K | n/a | 12K | 19K | 23K | 30K | 29K | 29K | 29K | 28K | 29K | 28K | 28K | 27K | 19K | 17K |
Add to Watchlist
Select watchlists to add or remove ORKA